This toolkit, jointly created by the World Health Organization (WHO) Regional Office for Europe and the European Centre for Disease Prevention and Control (ECDC), provides event organisers with customisable tools on monkeypox for mass gatherings, both for consideration and use.
In 2023, significant increases in the number of measles cases and outbreaks were observed globally, including in 40 of the 53 countries of the European region, and in at least ten EU/EEA countries.
The purpose of this toolkit is to provide investigators with a series of tools that can be useful during an investigation of a European FWD outbreak, i.e. an outbreak that involves at least two EU Member States.
ECDC and WHO have worked together to publish a series of examples of risk communication and community engagement (RCCE) strategies for public health authorities in the context of the ongoing monkeypox outbreak, building on previous RCCE advice.
This toolkit aims to support infection prevention in schools, with a focus on gastrointestinal diseases, by assisting EU/EEA countries in their communication initiatives for disease prevention in school settings.
A collection of ECDC guides related to communicating about immunisation. Communication toolkit on immunisation Supporting EU/EEA countries in their communication initiatives to increase immunisation uptake.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 14-20 January 2024 and includes updates on avian influenza, SARS-CoV-2 variant classification, an overview of respiratory viruses in the EU/EEA, mpox, measles, and Infant formula for medical purposes recalled due to possible contamination with Cronobacter sakazakii.
Schools are ideal settings to encourage hand washing and other good hygiene practices which can contribute to children, staff and others members of the school community learning effective ways to prevent infections.
ECDC releases a communication toolkit for seasonal influenza, with materials targeting healthcare workers and people at higher risk of developing flu-related complications.